Search

everythinglearnresearchcommunity

for

Search:↓

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Men with systemic lupus erythematosus often have more severe symptoms but can respond well to treatment.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

A woman with inflammatory bowel disease improved after treatment with ustekinumab for a rare skin condition associated with her disease.

Apremilast improved symptoms in patients with severe skin conditions.

Bempikibart may help regrow hair in people with alopecia areata.

JAK/STAT inhibitors show promise for skin diseases but aren't yet approved.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Machine learning can help identify biomarkers for personalized Pemphigus vulgaris treatment.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Hair dye may trigger anti-GBM disease relapse, and rituximab can help manage it.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

The treatment was effective for lupus nephritis with manageable side effects.

Leflunomide and methotrexate are equally effective for rheumatoid arthritis but have different side effects.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

AS101 reduces hair loss from chemotherapy.

Adalimumab significantly improved Hidradenitis Suppurativa and quality of life in two patients.

Apremilast helps regrow hair in hard-to-treat alopecia areata.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.